Whitehawk Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Whitehawk Therapeutics Inc.: Is Infosys Ltd. worth buying?
Item: Whitehawk Therapeutics Inc.
Rating: 2.08650
Author: Trendlyne DVM scores

about

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

2.70 -0.15 (-5.26%)

28.38% Fall from 52W High

70,344

XNAS Volume

XNAS 23 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

22.0 / 100

Technically Moderately Bullish

61.5 / 100

1Yr Price target upside is 67%

2 analysts

Whitehawk Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Whitehawk Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engine...

28.38% Fall from 52W High

SWOT Analysis

Whitehawk Therapeutics Inc Live Price Chart